Biotech Fund L.p. Efficacy is 10% at REPROS THERAPEUTICS INC. (RPRX). They have made 1 open-market trade across 1 company since 2009, most recently 2009-12-02.
CIK 0001366073
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RPRX | 3,488,136 | $212.7M |
Shares reported on the most recent Form 4, priced at the 2009-12-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RPRX | SELL | 2009-11-30 | 2009-12-02 | $0.71 | $381K | +18.4% | +1.1% | +1.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.